Justices Won't Hear Drugmakers' OxyContin Patent Appeal
Purdue Pharma LP and Grunenthal GmbH lost their bids to have the U.S. Supreme Court take up their challenge to a Federal Circuit's nix of asserted claims of four patents relating...To view the full article, register now.
Already a subscriber? Click here to view full article